Attached files
file | filename |
---|---|
8-K - FORM 8-K - Calumet Specialty Products Partners, L.P. | h81457e8vk.htm |
EX-1.1 - EX-1.1 - Calumet Specialty Products Partners, L.P. | h81457exv1w1.htm |
EX-10.1 - EX-10.1 - Calumet Specialty Products Partners, L.P. | h81457exv10w1.htm |
Exhibit 99.1
For more information:
Jennifer Straumins, 317-328-5660
jennifer.straumins@calumetspecialty.com
Jennifer Straumins, 317-328-5660
jennifer.straumins@calumetspecialty.com
FOR IMMEDIATE RELEASE
Calumet Specialty Products Partners, L.P. Announces Pricing of $400 Million Private Placement of
Senior Notes due 2019
Senior Notes due 2019
Indianapolis, IN (April 15, 2011) Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT)
(Calumet) and its wholly owned subsidiary Calumet Finance Corp. announced today the pricing of
their private placement under Rule 144A to eligible purchasers of $400 million in aggregate
principal amount of 9 3/8% senior unsecured notes due 2019 (the Notes). The offering size was
increased to $400 million from $375 million. The Notes mature on May 1, 2019 and will be issued
at par. The offering is expected to close on April 21, 2011, subject to customary closing
conditions. Calumet intends to use the net proceeds from the private placement to repay in full
all of the outstanding borrowings under its existing senior secured term loan facility, as well as
all accrued interest and fees, and for general partnership purposes.
The securities to be offered have not been registered under the Securities Act of 1933, as
amended (the Securities Act), or any state securities laws, and unless so registered, the
securities may not be offered or sold in the United States except pursuant to an exemption from, or
in a transaction not subject to, the registration requirements of the Securities Act and applicable
state securities laws. Calumet plans to offer and sell the notes only to qualified institutional
buyers pursuant to Rule 144A under the Securities Act and to persons outside the United States
pursuant to Regulation S.
This press release shall not constitute an offer to sell, or the solicitation of an offer to
buy, any of these securities, nor shall there be any sale of these securities in any state in which
such offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of such states.
This press release includes statements regarding the offering that may constitute
forward-looking statements. Such forward-looking statements are subject to a variety of known and
unknown risks, uncertainties, and other factors that are difficult to predict and many of which are
beyond managements control. Calumet undertakes no obligation to update or revise any
forward-looking statement to reflect new information or events.